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Abstract: Polyhydroxyalkanoates (PHAs) are a family of biopolyesters synthesized by various microorganisms. Due to their biocompatibility and biodegradation, PHAs have been proposed for
biomedical applications, including tissue engineering scaffolds. Olive leaf extract (OLE) can be
obtained from agri-food biowaste and is a source of polyphenols with remarkable antioxidant properties. This study aimed at incorporating OLE inside poly(hydroxybutyrate-co-hydroxyvalerate)
(PHBHV) fibers via electrospinning to obtain bioactive bio-based blends that are useful in wound
healing. PHBHV/OLE electrospun fibers with a size of 1.29 ± 0.34 µm were obtained. Fourier transform infrared chemical analysis showed a uniform surface distribution of hydrophilic -OH groups,
confirming the presence of OLE in the electrospun fibers. The main OLE phenols were released
from the fibers within 6 days. The biodegradation of the scaffolds in phosphate buffered saline was
investigated, demonstrating an adequate stability in the presence of metalloproteinase 9 (MMP-9), an
enzyme produced in chronic wounds. The scaffolds were preliminarily tested in vitro with HFFF2
fibroblasts and HaCaT keratinocytes, suggesting adequate cytocompatibility. PHBHV/OLE fiber
meshes hold promising features for wound healing, including the treatment of ulcers, due to the long
period of durability in an inflamed tissue environment and adequate cytocompatibility.
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Polyhydroxyalkanoates (PHAs) are biopolyesters synthesized by various microorganisms in the form of granular inclusions within the cells and accumulated as energy storage
materials. More than 90 genera of both Gram-positive and Gram-negative bacteria have
been identified as PHA producers under both aerobic and anaerobic conditions [1,2]. Recently, PHAs have been investigated as biomaterials due to their excellent biocompatibility
and biodegradability. The proposed applications of PHAs encompass medical and pharmaceutical devices, nanotechnology, tissue engineering scaffolds, cardiovascular patches,
and neural conduits, as well as wound dressings [3]. As a very wide family of biopolymers,
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PHAs possess a diverse chemical structure, enabling different molecular interactions that
give rise to a tunable range of material properties, including mechanical behavior and degradation kinetics [3,4]. Among PHAs, poly(hydroxybutyrate-co-hydroxyvalerate) (PHBHV),
is a copolymer investigated in the biomedical field. The presence of hydroxyvalerate (HV)
imparts better processability to the rigid polyhydroxybutyrate (PHB). As such, PHBHV
shows great potential for fabricating biomedical micro- and nanocarriers, being highly
soluble in organic solvents, such as chloroform and dichloromethane, and insoluble in
water [5]. In fact, PHBHV can be processed from the molten state, blended, and electrospun
using copolymer solutions [6,7]. Even though many conventional and non-conventional
technologies are available to produce scaffolds, electrospinning offers several advantages in
the field of tissue engineering. Indeed, this technique allows the simple and cost-effective
production of ultrafine fiber meshes, which, for their nature, mimic the fibrous extracellular
matrix (ECM) of biological tissues, usually formed by collagen and elastic fibers, with a
similar size [8].
Electrospinning exploits a simple key principle: a charged polymer solution jet is
formed and collected on a collector when the applied electrostatic charge overcomes the
surface tension of the polymer solution. As such, this technique can operate at room
temperature using an electric field as a driving force for fiber formation. For this reason, electrospinning is particularly suitable to incorporate bioactive molecules and drugs
into polymeric fibers, including PHBHV [9]. In a typical setting, electrospun fibrous scaffolds are assembled into nonwoven networks, which are deposited with an anisotropic
(i.e., random) fiber orientation using a static planar collector [10]. Such randomly deposited
fibrous meshes have potential applications, such as temporary substitutes for skin tissue
engineering, since they replicate the microstructure of the dermal connective tissue [11].
Moreover, the high surface area of electrospun fibrous scaffolds allows oxygen permeability
at the wound site, making these scaffolds suitable substrates for wound dressings [12].
Due to their tunable properties and biotech origin, PHAs and specifically PHBHV
are very competitive candidates to replace other materials, e.g., those produced by the
petrochemical industry, and have received increasing attention in the medical field for the
development of high purity polymers from cheap extraction and recovery methods [12,13].
Skin damage represents a healthcare challenge for the medical sectors, affecting several million people worldwide. Some of them may be long-standing and unresponsive
to conventional therapy due to complications from comorbidities, such as diabetes or
infection [14]. In fact, wound healing is a complex and dynamic process connecting a cascade of biological reactions initiated in response to an injury. The process mainly involves
the interaction of immune and non-immune cells (i.e., endothelial cells, fibroblasts, and
keratinocytes) with soluble mediators (e.g., cytokines and growth factors), and ECM components [15,16]. The rate of healing in acute wounds differs from that in chronic wounds
and is also dependent on the immunological status of the patient [17]. For example, the
healing of ulcers is a very complex process; several products have been made available to
facilitate its resolution [18]. Tissue-engineered skin replacements have been proposed as
novel approaches to aid the healing of difficult skin wounds, such as ulcers. The presence
of some biomolecules and biomaterials that improve the expression of defensins in the
epidermal cells of tissue-engineered skin could play an important role in supporting an
uncomplicated healing process [19,20]. However, several factors affecting the specific
tissue microenvironment, sustained by the perseverance of inflammation, still make ulcer
healing an unmet clinical need, which deserves additional research [21]. Among the many
biomolecules used in ulcer treatment, we focused on olive leaf extract (OLE), since it is rich
with polyphenols, namely powerful antioxidant molecules with a protective effect against
stress damage in tissues [22,23]. It incorporates hydrophilic phenolic compounds, mainly
secoiridoid oleuropein (about 17% w/w%), along with other compounds, such as apigenine7-O-glucoside, luteolin-7-O-glucoside, quercetin, and caffeic acid, present in lower amounts
(<0.1% w/w%) [24]. OLE is obtained from olive tree leaves as an agri-food biowaste during
pruning, which is usually burnt in plantations; as such, its use as a bioactive ingredient and
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food supplement is in line with green economy goals [25,26]. It is believed that OLE acts as
a free radical scavenger by a synergy of its many polyphenols. Therefore, it is an important
means for the local delivery of OLE inside ulcers, which simultaneously induce connective
tissue regeneration.
This study aimed to obtain bioactive bio-based PHBHV/OLE composites in the form
of fiber meshes to be useful in wound healing. OLE was prepared and characterized
for the content of polyphenols via high performance liquid chromatography (HPLC).
PHBHV/OLE ultrafine fiber meshes were produced by electrospinning a PHBHV/OLE
solution in appropriate solvents. The presence and distribution of OLE on the fiber surface
was assessed via Fourier transform infrared spectroscopy (FT-IR). An in vitro degradation
study was carried out to understand the stability of the scaffolds in biofluids. Finally,
the fiber meshes were cultured with human fibroblasts and keratinocytes to confirm their
cytocompatibility. Producing bioactive and fully bio-based scaffolds for ulcer repair is
expected to contribute to functional and eco-sustainable biomedical products for skin
damage.
2. Materials and Methods
2.1. OLE Preparation
Olive leaves were obtained from Olivastra seggianese plantation. The collection was
performed at CNR-IVALSA (Follonica, GR, Italy). Leaf collection was carried out manually
in March 2019. Leaves were placed in liquid nitrogen and crushed manually with a mortar
and pestle. Water was added to the leaf powder and then the mixture was homogenized
using a sonicator (IKA-Ultra Turrax Digital homogenizer at 100 rpm) for 1 min and a vortex
mixer for 30 s. After centrifugation at 4000 rpm for 5 min, at 25 ◦ C, the water phase was
filtered using a syringe with a 0.22 µm pore-sized polystyrene filter and collected using a
freeze-drier (Labconco, Kansas City, MO, USA), thus obtaining OLE.
2.2. OLE Characterization
The total phenol (TP) content in OLE was determined using the Folin–Ciocalteu
method and gallic acid as the standard equivalent (µg GAE/mg) (Merk, Darmstadt, Germany), following a reported procedure [27]. About 10 mg of OLE was dissolved in 10 mL
of CH3 OH-H2 O (80:20 v/v) and then an aliquot of this solution (1 mL) was mixed with
0.25 mL of Folin–Ciocalteu reagent (FCR) and 1.5 mL of Na2 CO3 water solution (20% w/v).
Afterwards, distilled water was added to reach the volume of 10 mL, and the resulting
mixture was kept for 45 min at a controlled temperature of 25 ◦ C. Spectrophotometric
analysis was performed at λ = 725 nm [28,29].
HPLC was carried out to identify and quantify the major phenolic compounds of the
OLE, using a slightly modified method that was developed in our previous study [24].
The retention times and UV absorbance spectra of phenolic compounds present in OLE
were compared to those of the commercial standard and quantified at 278 nm, using
p-hydroxyphenyl acetic acid as the internal standard, according to the previously reported
method [26]. Sample concentrations were subsequently determined by linear regression,
as a standard practice. For each calibration curve, the correlation coefficients were >0.99.
HPLC analysis was performed using Thermo Finnigan-Spectra System SCM1000 equipped
with a Spectra System P2000 (Pumps), Spectra System UV2000, set to 280 nm, and using a Phenomenex Gemini reverse-phase C18 column (250 × 4.6 mm, 5 µm particle size;
Phenomenex, Castel Maggiore, Italy). The mobile phase was a mixture of H2 O/acetic
acid (97.5:2.5 v/v) (called “A”) and acetonitrile (called “B”), following a published practice [24]. The system was programmed as follows: a linear gradient was run from 5% B
to 25% B for 20 min, followed by 50% B for 20 min, then 80% B for 10 min, and finally,
re-equilibration to initial composition for 5 min. The flow rate used was 1 mL/min and the
injected volume was 50.0 µL. Samples were injected as a mixture of methanol (MeOH; from
Sigma-Aldrich)/phosphate buffer saline (PBS; from Sigma-Aldrich) (1:1 v/v). To assess the
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phenol content, 10 mg of OLE powder was dissolved in PBS and subsequently analyzed
with HPLC.
Solvents used for HPLC analysis were purchased from Sigma Aldrich. Tyrosol, hydroxytyrosol, caffeic acid, and a p-coumaric acid, as analytical standards, were purchased
from TCI (Zwijndrecht, Belgium). Oleuropein and p-hydroxyphenylacetic acid were purchased from Sigma-Aldrich. Luteolin-7-O-glucoside, apigenin-7-O-glucoside, and rutin were
purchased from Extra synthese (Lyon, France). PBS for each analysis was diluted 10 times.
2.3. Fabrication of Electrospun PHBHV/OLE Fiber Meshes
PHBHV (with HV content 12% w/v%) was purchased from Sigma-Aldrich
(Milan, Italy). The solution was prepared by mixing dichloromethane (DCM; from Carlo
Erba (Rodano, MI, Italy) and MeOH (10:1 w/w). OLE at 16.5% w/w, with respect to PHBHV,
was dissolved in the solvent mixture by magnetic stirring overnight at room temperature.
The obtained PHBHV/OLE solution in DCM/MeOH was poured into a 10 mL glass syringe and placed into a syringe pump (NE-300, New Era Pump Systems, Inc., Farmingdale,
NY, USA). The ground terminal of high voltage supply (S1600079 Linari High Voltage,
Linari Engineering s.r.l., Pisa, Italy) was connected to the metal needle, whereas the positive
terminal was connected to the collector. The fibers were collected on a rotatory collector
set at quasi-zero velocity on aluminum foil to collect randomly oriented fibers with a
uniform mesh thickness. The fiber mesh was obtained using a tip-to-collector distance of
15 cm at a flow rate of 0.0016 mL/min and 30 kV. The mesh was electrospun for 1 h to
obtain self-standing samples. Humidity was 40% and temperature was 20 ◦ C throughout.
PHBHV fiber meshes without OLE were collected in the same way to be used as controls.
Image J software (version 1.52t) was used to evaluate the size of fibers. An average of 100
measurements was taken for each sample. After production, the fibers were left dry under
a laminar hood and stored at 4 ◦ C for further use to preserve phenolic compound activity.
Additionally, Image J was used to evaluate the percentage of the porosity of the fibers.
2.4. Characterization of PHBHV/OLE Electrospun Fibers
The morphology of the fiber meshes was evaluated using scanning electron microscopy
(SEM) using a FEI FEG-Quanta 450 instrument (Field Electron and Ion Company, Hillsboro,
OR, USA). The samples were sputtered with gold (Gold Edwards SP150B, UK) before
analysis. FT-IR in attenuated total reflectance (ATR) mode was used to characterize the
presence of specific chemical groups in the tested samples. Analysis of the bulk samples
was performed using Nicolet T380 instrument (Thermo Scientific, Waltham, MA, USA)
equipped with a Smart ITX ATR attachment with a diamond plate.
FT-IR analysis Chemical Imaging was then used to evaluate the surface distribution of
components in the biomaterial, obtaining chemical and correlation maps to visualize their
distribution. The micro-ATR (µATR) and spotlight FT-IR spectra maps were carried out by
means of a Perkin Elmer Spectrum One FTIR Spectrometer, equipped with a Universal ATR
Sampling Accessory and a Spectrum Spotlight 300 FT-IR Imaging System (Perkin Elmer,
Norwalk, CT, USA), using the image mode of the instrument. For each sample, areas of
1 mm × 1 mm were analyzed. Afterwards, an IR image was generated using a nitrogencooled, 16-pixel mercury cadmium telluride line detector at a resolution of 25 µm per pixel.
An absorbance spectrum was recorded for each pixel in the µATR mode. Spotlight software
used for the acquisition was also employed to pre-process the spectra. Consequently, the
spectra images were analyzed with a reference correlation image. Additionally, the full
spectral maps were analyzed by principal component analysis (PCA). For this analysis, the
data set was composed of the spectra that make up the full spectral image. The spectral data
grouping of similar variability is represented by the same color, allowing the identification
of different spectral groups.
The quantity of phenolic compounds incorporated inside the polymer fibers was
investigated using 4 cm2 square meshes incubated in MeOH and the resulting solution was
analyzed by HPLC, as described in Section 2.2.
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2.5. Degradation Study of PHBHV/OLE Electrospun Fibers
A complete degradation analysis was carried out in vitro on PHBHV/OLE electrospun
fibers. The tests were conducted by soaking samples of the fiber meshes (size 1 × 1 cm2 ;
weight 5 mg) in PBS and placing them in a 37 ◦ C oven for up to 2 months. To understand the
sample susceptibility to enzymatic degradation, a set of samples (n = 4) were soaked in PBS
with metalloproteinase 9 (MMP-9; from Sigma-Aldrich), at 10 ng in 200 µL of PBS for a final
volume of 1.5 mL per sample, at room temperature. The solution was replaced every week.
Every week, the samples were carefully removed from the solutions, dried under a laminar
flow hood for 2 h, and weighted in an analytic balance (AS 220.R2, RADWAG, Poland). The
morphology of the samples was observed via SEM. The analysis of degraded samples was also
investigated by molecular loss mass, using GPC (Perkin Elmer, USA). Chloroform was used as
the mobile phase and its constant flow-rate was maintained at 1.0 mL/min. Polymer sample
solutions were prepared by dissolving samples (0.5% w%) in chloroform (1 mL) and sterile
filtering (0.45 µm filters). A total volume of 100 µL was used for GPC analysis. Calibration
was performed using the standards of polystyrene to determine the number-average and
weight-average molecular weights (Mn and Mw) of samples.
2.6. In Vitro Phenol Release Study
To investigate the release of phenols from PHBHV/OLE, the diffusion of phenolic compounds in a release medium (i.e., PBS) was determined. A 4 cm2 square of PHBHV/OLE
was inserted into a 3 cm diameter well of a multi-well plate and 2 mL of PBS was added to
each well. Then, the plate containing the solutions was incubated in an oven at a controlled
temperature of 37 ◦ C. At defined time intervals (0, 0.5, 1, 1.5, 2, 2.5, 3, 4, 6, 24, 48, 72, 144 h),
the supernatant was removed, the well was washed with 1 mL of PBS and an equal amount
of the fresh PBS (2 mL) was replaced each time [30,31]. The qualitative-quantitative evaluation of the phenols released from the polymer was carried out by HPLC analysis, following
a previously reported method [32].
2.7. Cytocompatibility of PHBHV/OLE Fiber Scaffolds
Human Caucasian foreskin fetal fibroblasts (HFFF2) (ICLC #Catalog HL95002), were
kindly provided from IRCCS AOU San Martino, National Institute for Cancer Research,
Italy. The cells were cultured with Dulbecco’s Modified Eagle Medium (DMEM) with 10%
fetal bovine serum (FBS), 2 mM L-Glutamine, and 1% penicillin-streptomycin solution
(all from Lonza, Walkersville, MD, USA) in T75 tissue culture flasks (Euroclone S.p.A, Pero,
MI, Italy). The cells were seeded at 2 × 104 cells/cm2 in 75 cm2 in tissue culture polystyrene
(TCPS) flasks to allow expansion. Cell cultures were performed in a humidified incubator
set at 37 ◦ C in 5%CO2 /95% air.
The scaffolds were cut to measure 1 × 1 cm2 and sterilized under UV light for
30 min. Before seeding, the scaffolds were soaked with a sterile-filtered 2% (w/v) gelatin
(type B, from bovine skin; Sigma Aldrich) aqueous solution by soaking for 30 min to facilitate cell adhesion. Excess gelatin solution was removed before cell seeding. HFFF2 cells
were detached from the TCPS flasks using trypsin 0.25% (v/v%)/ethylenediaminetetraacetic
acid (EDTA) (Euroclone S.p.A.) and seeded on PHBHV and PHBHV/OLE fiber meshes
at a density of 2 × 105 cells/20 µL in culture medium per scaffold, placed in a 24-well
plate. Cell/scaffold constructs were cultured in 1 mL of culture medium replaced every
2 days for 1 week. At the endpoint, 72 h after seeding, the metabolic activity of cell/scaffold
constructs was evaluated using resazurin dye (Sigma-Aldrich), dissolved at a concentration of 0.5 mg/mL in a culture medium and incubated with the samples for 4 h. The
dye contains a REDOX indicator, turning from blue into pink, after being metabolized
by cells. The absorbance (λ) of supernatants was measured with a spectrophotometer
(Victor 3; PerkinElmer, Waltham, MA, USA) under a double wavelength reading (570 nm
and 600 nm). Finally, the dye reduction percent (%red) was calculated, correlating the absorbance values and the molar extinction coefficients of the dye at the selected wavelengths.
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The equation applied is shown below (Equation (1)), in which λ = absorbance, s = sample,
and c = control.


117, 216·λs(570 nm) − 80, 586·λs(600 nm)

(1)
%Dyered = 100· 
155, 677·λc(600 nm) − 14, 652·λc(570 nm)
At the endpoint, the cell/scaffold constructs were washed two times with PBS and
fixed in 1% (w/v) neutral buffered formalin for 10 min at 4 ◦ C. Formalin-fixed samples were washed again with PBS and permeabilized with 0.1% (v/v) triton (Sigma)
in PBS for 5 min, prior to being incubated with phalloidin Alexa Fluor 633 (Thermo
Fisher Scientific) for 45 min at room temperature in the dark, following the manufacturer’s procedure. Counterstaining was performed by incubating the sample in 10 µg/mL
40 ,6-diamidino-2-phenylindole (DAPI, Thermo Fisher Scientific, Waltham, MA, USA) in PBS
for 10 min at room temperature in the dark. Specimens were observed using an inverted
fluorescence microscope equipped with a digital camera (Nikon Eclipse Ti, Amsterdam,
The Netherlands).
Cytocompatibility was also investigated using human keratinocytes. HaCaT cell line
was obtained from CLS–Cell Lines Service, Eppelheim, Germany. Cells were expanded, as
reported above for HFFF2, and finally seeded at 1 × 105 cells/20 µL in culture medium per
sterile scaffold and placed in 24-well plates as previously reported. Cell/scaffold constructs
were cultured for 72 h. At the endpoint, the samples were fixed in 10% formalin for 10 min,
rinsed in distilled water, and dried in a vacuum oven set at 37 ◦ C. The specimens were
mounted on aluminum stumps, sputter-coated via an argon gas carrier for 15 s (Coater
SC7620, Quorum Technologies Ltd., West Sussex, UK), and observed by SEM.
2.8. Statistical Analysis
Statistical analysis was carried out by Microsoft Office Excel and shown as mean
± standard deviation (SD) using Student’s t-test. Probability (p) values < 0.05 were considered to be statistically significant differences.
3. Results
3.1. OLE Characterization
The TP content of OLE was estimated using the Folin–Ciocalteu method, resulting in
58.47 µg GAE/mg. Furthermore, HPLC analysis allowed the main polyphenols present
in OLE to be determined, which were reported in Table 1. They were oleuropein and
luteolin-7-O-glucoside, with a concentration of 32.64 ± 3.06 mg/g of OLE (3.26 w/w%) and
6.97 ± 0.24 mg/g of OLE (0.70 w/w%), respectively; moreover, OLE contained
apigenin-7-O-glucoside with a concentration of 1.97 ± 0.17 mg/g of OLE (0.20 w/w%),
rutin with a concentration of 3.37 ± 0.33 mg/g of OLE (0.34 w/w%), and other compounds
(hydroxytyrosol, caffeic acid, and p-coumaric acid) with a concentration lower than
1 mg/g of OLE.
Table 1. Content (mg/g) of main phenols in OLE (mg/g of OLE). Data are expressed as mean ±
standard deviation (SD) (n = 2).
Hydroxy-Tyrosol

Caffeic Acid

p-Coumaric Acid

Rutin

Luteolin-7-OGlucoside

Apigenin-7-OGlucoside

Oleuropein

0.85 ± 0.08

0.18 ± 0.02

0.085 ± 0.007

3.37 ± 0.33

6.97 ± 0.24

1.97 ± 0.17

32.64 ± 3.06

3.2. Characterization of PHBHV/OLE Fiber Meshes
Morphological properties of the PHBHV and PHBHV/OLE fibers were investigated
via SEM. The fibrous meshes resulted in smooth fiber surfaces in both electrospun types.
Additionally, the PHBHV/OLE fiber meshes showed differences in porosity with 42.22%
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As evidenced in the spectra of OLE-containing samples, the band at 3300 cm−1 is
indicative of molecular -OH groups related to the hydrophilicity of the extract due to the
presence of phenols. In the spectra, the absorption bands between 1700–1738 cm−1 , related
to the C=O groups of PHBHV and OLE, were also indicated, which is confirmed in the
literature [33]. The characteristic peak at 2925 cm−1 may be attributed to the C-H stretching
node, which in OLE is present in the terminal methyl groups, while the peak of 1624 cm−1
is attributed to the presence of amide I. Chemical imaging maps acquired in FT-IR show
the homogeneous presence of -OH groups, ascribable to OLE, on the mesh surface, thus
indicating an optimally dispersed composite material (Figure 3).
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graph of FT-IR spectra.
graph of FT-IR spectra.

A degradation analysis was carried out in vitro on PHBHV/OLE scaffolds, using PBS
A degradation analysis was carried out in vitro on PHBHV/OLE scaffolds, using PBS
and PBS with MMP-9. The mass loss evaluated using an analytical balance up to 56 days
and PBS with MMP-9. The mass loss evaluated using an analytical balance up to 56 days
is reported in Table 2. After 56 days, the average gravimetric weight loss percentage of
is reported in Table 2. After 56 days, the average gravimetric weight loss percentage of
fibers containing OLE after incubation in PBS was 4.21%, while after incubation in PBS
fibers containing OLE after incubation in PBS was 4.21%, while after incubation in PBS
with
MMP-9, the
the weight
weight loss
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reached 9.6%
9.6% (Table
(Table 2).
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Table 2. Gravimetric weight loss (mg/mg %) of PHBHV/OLE fibers in different media: PBS and PBS
added with MMP-9. Data are expressed as mean ± SD (n = 4).
added with MMP-9. Data are expressed as mean ± SD (n = 4).
Time
(days)
12
28
42
56

Weight Loss (mg/mg %) in Degradation Media:
Time
Degradation Media:
(days) Weight Loss (mg/mg %) inPBS
PBS + MMP-9
PBS
PBS + MMP-9
12
2.76 ± 0.07
2.44 ± 0.07
2.44 ± 0.07
28 2.76 ± 0.07
3.33 ± 0.11
3.75 ± 0.11
3.33 ± 0.11
3.75 ± 0.11
42 3.85 ± 0.11
3.85 ± 0.11
7.14 ±7.14
0.02± 0.02
56 4.21 ± 0.14
4.21 ± 0.14
9.64 ±9.64
0.28± 0.28
The change of molecular weight of PHBHV/OLE fiber meshes after incubation in PBS
The change of molecular weight of PHBHV/OLE fiber meshes after incubation in PBS
with MMP-9 was evaluated by GPC. Molecular weight reduction as a function of time due
with MMP-9 was evaluated by GPC. Molecular weight reduction as a function of time due
to the breakdown of the copolymer chains was observed. In the first two weeks, the rupto the breakdown of the copolymer chains was observed. In the first two weeks, the rupture
ture of PHBHV chains was, on average but not significantly, higher when the fibers with
of PHBHV chains was, on average but not significantly, higher when the fibers with OLE
OLE were incubated in PBS with the MMP-9 enzyme, whereas in the following weeks, the
were incubated in PBS with the MMP-9 enzyme, whereas in the following weeks, the4 rate
rate of degradation was similar in two incubation media, decreasing by about 28 × 104 kDa
of degradation was similar in two incubation media, decreasing by about 28 × 10 kDa
(Figure 4). SEM morphological analysis is reported in Figure 5.
(Figure 4). SEM morphological analysis is reported in Figure 5.
Morphological analysis showed gradual changes in the surface of the fibers including
the formation of pores and cracks, particularly evident after 4 weeks (Figure 5C,D), while
maintaining the mesh structure. This result is in agreement with the gravimetric outcomes,
showing a partial bulk erosion lower than 10% after 8-week incubation in the presence
of MMP-9.
The phenolic content of PHBHV/OLE obtained via HPLC analysis indicated that the
amount of main phenols present was 21.84 ± 0.14 µg for oleuropein, 7.22 ± 0.78 µg for
luteolin-7-O-glucoside, and 3.54 ± 0.13 µg for apigenin-7-O-glucoside.
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Table 3.
PHBHV/OLE
PHBHV/OLEfiber
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mesh.Data
Dataare
areexpressed
expressedas
asmeans
means±±SD
SD(n(n= =2).2).
Time (h)
0
0.5
1.0
1.5
2.0
3.0
4.0
6.0
24.0
48.0
72.0
144.0

Time (h) Luteolin-7-O-Glucoside Apigenin-7-O-Glucoside
Luteolin-7-O-Glucoside
Apigenin-7-O-Glucoside
0
0.00
0.00
0.00
0.00
0.5 3.44 ± 0.85 3.44 ± 0.85
0.95 ± 0.04
0.95 ± 0.04
1.0 3.48 ± 1,45 3.48 ± 1,45
1.58 ± 0.49
1.58 ± 0.49
4.01
±
1.58
1.86
±
0.71
1.5
4.01 ± 1.58
1.86 ± 0.71
2.10 ± 0.94
2.0 4.37 ± 1.75 4.37 ± 1.75
2.10 ± 0.94
4.68 ± 1.95
2.25 ± 0.98
3.0
4.68 ± 1.95
2.25 ± 0.98
4.81 ± 1.93
2.31 ± 0.90
4.0 5.05 ± 2.01 4.81 ± 1.93
2.31 ± 0.90
2.52 ± 1.20
6.0 5.64 ± 2.20 5.05 ± 2.01
2.52 ± 1.20
2.95 ± 1.37
3.07 ± 1.43
24.0 5.87 ± 2.22 5.64 ± 2.20
2.95 ± 1.37
- 3.07 ± 1.43
48.0 6.08 ± 2.23 5.87 ± 2.22
6.47 ± 2.21
72.0
6.08 ± 2.23
144.0
6.47 ± 2.21
3.4. Cytocompatibility of the Scaffolds Using HFFF2 Cells

Oleuropein
0.00
0.00
12.29 ± 1.30
12.29 ± 1.30
14.53
± 2.60
14.53
± 2.60
15.70
±
2.96
15.70 ± 2.96
16.53
± 2.79
16.53
± 2.79
17.63 ± 2.52
17.63 ± 2.52
18.49 ± 2.15
18.49
± 2.15
19.38
± 1.92
19.38
± 1.92
20.93
± 2.45
21.75
± 2.85
20.93
± 2.45
- ± 2.85
21.75
Oleuropein

A cytocompatibility study of PHBHV and PHBHV/OLE was performed in vitro using
HFFF2 and HaCaT cell lines. The results are shown in Figure 7. The resazurin test was
performed at 72 h after seeding, when the release of oleuropein and apigenin-7-O-glucoside
was complete and the release of luteolin-7-O-glucoside was at 94.01% (Figure 7A). By
comparing to the pure copolymer fibers, PHBHV/OLE fiber scaffolds showed the highest
metabolic activity of the HFFF2 fibroblasts, namely 69.5% ± 3.2% (p < 0.01). As the test was
performed against negative controls (scaffolds + dye, without cells), the quantitative results
are intended only for intra-sample comparison. The presence of cells adhered to the fibers
is confirmed by fluorescence micrographs (Figure 7B,C).
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4. Discussion
Chronic wounds, such as ulcers, represent an unsolved problem worldwide [14].
Chronic wounds, such as ulcers, represent an unsolved problem worldwide [14]. ConConcomitant factors, such as diabetes, sustain unhealed conditions for weeks and months
comitant factors, such as diabetes, sustain unhealed conditions for weeks and months
by interfering with the natural repairing process, thus leading to open wounds prone to
by interfering with the natural repairing process, thus leading to open wounds prone to
infections
search
forfor
new
dressings
ableable
to support
wound
healing
is still
infections[15,16].
[15,16].The
The
search
new
dressings
to support
wound
healing
is onstill
going.
It
is
expected
that
naturally
derived
materials
and
molecules
can
open
new
routes
ongoing. It is expected that naturally derived materials and molecules can open new routes
for
thisthis
purpose,
wewe
investigated
a novel
classclass
of biformanaging
managingchronic
chronicwounds
wounds[34].
[34].ForFor
purpose,
investigated
a novel
of
opolymers,
PHAs,
blended
with
olive-leaf-derived
polyphenols.
Specifically,
we
prepared
biopolymers, PHAs, blended with olive-leaf-derived polyphenols. Specifically, we prepared ultrafine fiber meshes made of PHBHV and OLE blends, having the morphological,
physico-chemical, cytocompatibility, and functional properties that make them suitable
scaffolds for skin repair. In fact, electrospinning of polymer blends is exploited to tune the
scaffold properties to reach the desired features [35]. The extraction phase of OLE allowed a
mixture of active principles to be obtained, which can be entrapped in the fibers to improve
biological functions by releasing the biomolecules over time [14,36]. The procedure of electrospinning, including the set-up of the solvent system, was optimized to produce meshes
of fibers, forming highly porous structures. In vitro tests carried out on PHBHV/OLE
meshes demonstrated a long-term biodegradation, and an improved cytocompatibility
with respect to OLE unloaded scaffolds. In addition, the electrospun mesh could serve as a
biomolecule carrier for a controlled release of antioxidant principles able to treat human
tissue alterations.
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Concerning the physicochemical characterization of PHBHV and PHBHV/OLE by
FT-IR, the analysis indicated an absorption band at 1700–1738 cm−1 that corresponds to the
C=O group of PHAs in both samples and a band in 3300–3200 cm−1 that contains several
vibration modes, present only in the sample with OLE, which is associated with hydroxyl
groups including those of adsorbed water [33]. The latter band can be considered as an
index of the material hydrophilicity degree, due to OLE incorporation into the PHBHV
fibers. In addition, the chemical map associated with -OH groups confirmed the efficiency
of the loading procedure of OLE and a homogeneous distribution of OLE over the whole
mesh. The results strongly suggest that OLE can be present both on the surface and inside
the PHBHV fibers. In fact, the FT-IR instrument used in ATR mode can detect the material
composition up to a 1 µm depth, which is of the same order of magnitude of the diameter
of the fibers (1.29 ± 0.34 µm).
An in vitro biodegradation study was carried out on the PHBHV/OLE samples for
a period of two months by immersing the samples in PBS and PBS with MMP-9, aimed
to resemble the conditions of a normal tissue remodeling process. It is known, in fact,
that MMP-9 is a proteolytic enzyme highly expressed during the wound healing process
and its proteolytic activity can allow ECM degradation, thus delaying wound healing [37].
At different time-points of incubation in two distinct media, the samples were analyzed
by measuring the weight loss. The results show a slow degradation with a modest mass
reduction at the endpoint, both in PBS (4.21%) and in PBS in the presence of MMP-9
(9.64%). In general, PHA films (i.e., PHB, PHBHV) are reported to have a slow hydrolytic
degradation in vitro, namely only 5% of their initial weight after 240 days in PBS [37]. In our
study, a slightly higher erosion was observed, which can be attributed to the hydrophilic
contribution of OLE within the PHBHV fiber structure. In addition, the presence of OLE
could favor the surface adsorption of MMP-9 molecules in the ester groups of PHBHV,
which finally resulted in an increased degradation due to the combined enzymatic and
hydrolytic effects. In this respect, GPC outcomes showed an evident reduction of molecular
mass, thus indicating the breakdown of ester bonds in the polymeric chains without an
evident bulk erosion, as also observed by SEM analysis. The trend of molecular weight
change showed how the hydrolytic process was responsible for the rupture of copolymeric
chains with a similar behavior in the two different media. The effect of the enzyme on
the corresponding erosion process was therefore observed for longer durations as pointed
out by the weight loss and morphological aspect of the PHBHV/OLE fibers after 8 weeks.
Salguero et al. assessed the PHB degradation in vitro, using the same protocol performed
in abiotic conditions, namely PBS at pH 7 and at 37 ◦ C for 40 days [38]. After this period,
their results showed a limited PHB mass loss, ranging in 1.0–1.5%. Finally, the use of an
enzyme permitted an increased time control upon polymer degradation [38]. During the
degradation, the enzymes break the long polymeric chain, forming oligomers and, after
some time, these oligomers may be hydrolyzed to monomeric units of the polymer [39,40].
OLE showed a release profile in our PHBHV fiber samples that was differently tuned
according to the diverse bioactive components. Indeed, biomolecules, such as oleuropein
and apigenin-7-O-glucoside, were fully released from the PHBHV fibers at 48 h, while
luteolin-7-O-glucoside were released at 144 h. Such a long-time release of polyphenols
(4–6 days) shows potential for the application of the PHBHV/OLE fibrous meshes for
wound healing, due to the properties of OLE. Patients suffering from skin ulcers—usually,
secondarily to other pathologies, such as diabetes—have a delayed healing time; they
may take drugs, either orally or directly applied to the skin [12]. The rapid release of the
biomolecules in OLE and the topical action, enhanced by the large surface area provided by
the electrospun fibrous material, can be considered an ideal strategy to deliver polyphenols
as a “natural drug” to the damage site, especially in chronic wounds of the skin [7,41–43].
In our preliminary tests of cytocompatibility, human fibroblasts and human keratinocytes
were able to grow on the PHBHV/OLE electrospun meshes in vitro. The former feature
is particularly impellent in partial and full thickness wounds, thus fibroblast infiltration
in electrospun scaffolds is highly desirable [44]. In addition, keratinocytes covered the
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scaffold surface through cellular layers, which is indicative of epithelization capacity. We
have recently disclosed the immunomodulatory activity of other PHA/OLE fibers in vitro
using human dermal keratinocytes occurring via the downregulation of the inflammatory
pattern, thus proving the potential for skin re-epithelization and regeneration, which are
secondary to inflammation resolution [45].
Lastly, even though the antimicrobial properties of OLE are still controversial, we have
recently demonstrated that OLE can induce the expression of the antimicrobial peptide
human defensin 2 (HBD-2) gene in human dermal keratinocytes, thus highlighting a
potentially powerful effect in chronic wound repair [32]. Moreover, we have also unveiled
new strategies to enhance the antimicrobial effect by combining OLE with other green
technologies, such as cold atmospheric plasma [46].
The produced biofunctional ultrafine fibers may represent a bio-based scaffold which
is sufficiently stable in an inflamed tissue environment, as demonstrated by its long degradation time, even in presence of MMP-9, showing promise for the medical application of a
new generation of green wound dressings. Producing new natural-based biomaterials that
are able to reduce inflammation, increase innate immune response, and provide a suitable
architecture for dermal and epidermal tissue regeneration over a long time could greatly
help the management of chronic wounds.
5. Conclusions
We demonstrated that OLE could be efficiently incorporated inside PHBHV electrospun scaffolds with a fiber size of 1.29 ± 0.34 µm, thus tuning the hydrophilic properties at the fiber surface. The PHBHV/OLE meshes highlighted a very long degradation
time in vitro, showing a weight loss of 4.21% ± 0.14% in PBS and 9.64% ± 0.28% in PBS
added with MMP-9 after 8 weeks. The copolymer molecular weight reduction was about
28 × 104 kDa in both degradation media, and surface erosion phenomena due to nanopore
formation on the fibers in PBS were detected. The release of the main polyphenols of OLE
from the fibers was assessed, showing a release occurring within 4–6 days. Finally, the
first observation with fibroblasts confirmed that the produced fibers were cytocompatible.
Due to all of these characteristics, they appear to be promising in medical applications
including wound healing and possibly skin ulcers. The utilization of PHBHV and OLE thus
represents a prospective strategy in biomedicine, which is also compliant with sustainable
use, a long period of durability, adequate biocompatibility, and environmental friendliness.
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